Jason Silvers's most recent trade in Generate Biomedicines Inc was a trade of 295,608 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generate Biomedicines Inc | Jason Silvers | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 295,608 | 295,608 | - | - | Stock Option (Right to Buy) | |
| Generate Biomedicines Inc | Jason Silvers | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 274,493 | 274,493 | - | - | Stock Option (Right to Buy) | |
| Generate Biomedicines Inc | Jason Silvers | President & CFO | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 26 Feb 2026 | 1,000 | 1,000 | - | 16 | 16,000 | Common Stock |
| Generate Biomedicines Inc | Jason Silvers | President & CFO | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 26 Feb 2026 | 500 | 500 | - | 16 | 8,000 | Common Stock |
| Generate Biomedicines Inc | Jason Silvers | President & CFO | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 26 Feb 2026 | 500 | 500 | - | 16 | 8,000 | Common Stock |